Intelligent Medicine Acquisition Corp. Unit
IQMDU
IQMDU was delisted on the 26th of April, 2023.
20 hedge funds and large institutions have $32.4M invested in Intelligent Medicine Acquisition Corp. Unit in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 7 closing their positions.
23% less funds holding
Funds holding: 26 → 20 (-6)
25% less capital invested
Capital invested by funds: $43M → $32.4M (-$10.6M)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$53.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$484 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
-$8.06M |
| 2 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
-$1M |
| 3 |
VF
Virtu Financial
New York
|
-$531K |
| 4 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$503K |
| 5 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
-$503K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIP
26
Ahrens Investment Partners
Lafayette,
Louisiana
| – | -$9K | -900 | Closed |
|
|
27
UBS Group
Zurich,
Switzerland
| – | +$484 | +48 | New |
|
IQMDU Hedge Fund Activity: Q3 2022 in Review
20 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Unit (IQMDU) for Q3 2022, worth a combined $32.4M — down 25% from $43M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of IQMDU and 1 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 1 added.
The largest buyer was Clear Street, adding an estimated $53.9K. The largest seller was HGC Investment Management, cutting an estimated $8.06M.
- 20 institutional investors held Intelligent Medicine Acquisition Corp. Unit (IQMDU) as of Q3 2022, down from 26 in Q2 2022.
- Funds reported $32.4M of Intelligent Medicine Acquisition Corp. Unit stock for Q3 2022, down 25% quarter-over-quarter.
- 1 fund opened new Intelligent Medicine Acquisition Corp. Unit positions in Q3 2022 and 7 closed out, a net change of -6 holders.
- The largest Intelligent Medicine Acquisition Corp. Unit buyer in Q3 2022 was Clear Street, an estimated $53.9K added.
- The largest Intelligent Medicine Acquisition Corp. Unit seller in Q3 2022 was HGC Investment Management, an estimated $8.06M sold.
Based on aggregated 13F filings for Q3 2022.